# Accuray

Source: https://onco.cc/companies/accuray/  
OnCo record `accuray` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Accuray makes the CyberKnife robotic radiosurgery system and the TomoTherapy and Radixact helical radiotherapy platforms, and sponsors trials of stereotactic and adaptive radiotherapy.

## Summary

Accuray, listed on Nasdaq and headquartered in Madison, Wisconsin after moving from Sunnyvale, California, manufactures radiotherapy equipment: the CyberKnife, a linear accelerator on a robotic arm that tracks tumour motion for stereotactic radiosurgery and stereotactic body radiotherapy, and the TomoTherapy and Radixact systems, which deliver helical intensity-modulated radiotherapy with daily imaging. It sponsors clinical trials of hypofractionated and adaptive treatment on its platforms. It appears on OnCo as a lead sponsor of phase 3 cancer trials on ClinicalTrials.gov.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: Accuray Incorporated; Accuray Inc.
- Tags: ctgov-sponsor
- HQ: Madison, WI
- Type: devices
- Website: https://www.accuray.com

## Sources

- Official website: https://www.accuray.com
- ClinicalTrials.gov: trials led by Accuray: https://clinicaltrials.gov/search?lead=Accuray
- Wikipedia: https://en.wikipedia.org/wiki/Accuray

## Connected records

- fronts: [Devices & Physical Therapies](https://onco.cc/fronts/devices/), [Radiation Therapy](https://onco.cc/fronts/radiation/)
- technologies: [SBRT / SABR (stereotactic radiotherapy)](https://onco.cc/technologies/sbrt/)
- terms: [Hypofractionation (fewer, larger radiotherapy doses)](https://onco.cc/terms/hypofractionation/), [Radiotherapy](https://onco.cc/terms/radiotherapy/)

---
JSON: https://onco.cc/api/v1/entities/accuray.json